3[1]Zaidi AM,Fitzpatrick AP,KeenanD JM,et al.Good outcomes from cardiac surgery in the over 70s [J].Heart,1999,82:134 -137.
4Lord RA, Roath OS, Thompson JF, et al. Effect of aprotinin on neutrophil function after major vascular surgery. Br J Surg, 1992 , 79:517-521.
5Hill GE, Pohorecki R, Alonso A, et al. Aprotinin reduce interleukin-8 production and neutrophil accumulation after cardiopulmonary bypass. Anesth Analg , 1996, 83: 696-700.
6Levy JH, Bailey JM, Salmenpera M, et al. Pharmacokinetics of aprotinin in preoperative cardiac surgical patients. Anesthesiology,1994, 80:1013-1018.
7Sganga G, Siegel JH, Coleman B, et al. The physiologic meaning of the respiratory index in various type of critical illness. Cir Shock,1985, 17:179-193.
8Dauber IM , Parsons PE, Aek L, et al. Peipherial bypass-induced pulmonary and coronary vascular injury. Assosiattion with increased levels of tumor necrosis factor cardiopulmonary bypass. Circulation,1993, 88: 726-735.
9Royston D. Aprotinin prevents bleeding and has effects on platelets and fibrinolysis. J Cardiothorac Vasc Anesth , 1991, 5 ( Suppl 1 ):18-23.
10Jansen NJ, Van Oeveren W, Vanden Broek L, et al. Inhibition of dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg , 1991, 102: 515-525.
9Karadeniz U,E rdemli O, Yamak B,et al. On — pump beatingheart versus hypothermic arrested heart valve replacement sur-gery [J] . J Card Surg,2008,23(2) : 107-113.
10Salemo TA,Panos AL’Tian G,et al. Surgery for cardiac valvesand aortic root without cardlop legic arrest ( “ beating heart” ):experience with a new method of myocardial perfusion [ J] . JCard Surg,2007,22(6):459-464.
